Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm)

Valeria Brazzelli, Francesca Prestinari, Michela Castello, Eleonora Bellani, Elena Roveda, Tania Barbagallo, Giovanni Borroni

Research output: Contribution to journalArticle

Abstract

We report our experience with UV-B narrowband (UV-B-NB) therapy in children affected by vitiligo. We studied 10 Caucasian Italian children (six boys, four girls, mean age 9.7 years ± 2.67). Treatment mean term was 5.6 months; frequency was three times a week on nonconsecutive days or only twice a week, because of school or family duties. The percentage of repigmentation was evaluated by comparing photographs taken before, during, and after the treatment, and showed a repigmentation level higher than 75% in five patients (5/10, 50%) and between 26% and 75% in three patients (3/10, 30%). Of our patients, 80% had a satisfactory response to phototherapy. Adverse events were limited and transient. No significant relationships between repigmentation grades and variables such as skin type, positive family history, and disease extension were observed. Some areas responded better than others; the best results were shown on the face and neck. Perhaps we studied too few patients to be conclusive, but the results obtained so far seem to indicate that children affected by recent vitiligo have a better response to the therapy. We feel that UV-B-NB therapy is a valuable and safe option for the treatment of pediatric vitiligo, and should be started as soon as possible.

Original languageEnglish
Pages (from-to)257-261
Number of pages5
JournalPediatric Dermatology
Volume22
Issue number3
DOIs
Publication statusPublished - May 2005

Fingerprint

Vitiligo
Therapeutics
Phototherapy
Neck
Pediatrics
Skin

ASJC Scopus subject areas

  • Dermatology
  • Pediatrics, Perinatology, and Child Health

Cite this

Brazzelli, V., Prestinari, F., Castello, M., Bellani, E., Roveda, E., Barbagallo, T., & Borroni, G. (2005). Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatric Dermatology, 22(3), 257-261. https://doi.org/10.1111/j.1525-1470.2005.22319.x

Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). / Brazzelli, Valeria; Prestinari, Francesca; Castello, Michela; Bellani, Eleonora; Roveda, Elena; Barbagallo, Tania; Borroni, Giovanni.

In: Pediatric Dermatology, Vol. 22, No. 3, 05.2005, p. 257-261.

Research output: Contribution to journalArticle

Brazzelli, V, Prestinari, F, Castello, M, Bellani, E, Roveda, E, Barbagallo, T & Borroni, G 2005, 'Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm)', Pediatric Dermatology, vol. 22, no. 3, pp. 257-261. https://doi.org/10.1111/j.1525-1470.2005.22319.x
Brazzelli, Valeria ; Prestinari, Francesca ; Castello, Michela ; Bellani, Eleonora ; Roveda, Elena ; Barbagallo, Tania ; Borroni, Giovanni. / Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). In: Pediatric Dermatology. 2005 ; Vol. 22, No. 3. pp. 257-261.
@article{1757cb6ec66246198446d141e990bedf,
title = "Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm)",
abstract = "We report our experience with UV-B narrowband (UV-B-NB) therapy in children affected by vitiligo. We studied 10 Caucasian Italian children (six boys, four girls, mean age 9.7 years ± 2.67). Treatment mean term was 5.6 months; frequency was three times a week on nonconsecutive days or only twice a week, because of school or family duties. The percentage of repigmentation was evaluated by comparing photographs taken before, during, and after the treatment, and showed a repigmentation level higher than 75{\%} in five patients (5/10, 50{\%}) and between 26{\%} and 75{\%} in three patients (3/10, 30{\%}). Of our patients, 80{\%} had a satisfactory response to phototherapy. Adverse events were limited and transient. No significant relationships between repigmentation grades and variables such as skin type, positive family history, and disease extension were observed. Some areas responded better than others; the best results were shown on the face and neck. Perhaps we studied too few patients to be conclusive, but the results obtained so far seem to indicate that children affected by recent vitiligo have a better response to the therapy. We feel that UV-B-NB therapy is a valuable and safe option for the treatment of pediatric vitiligo, and should be started as soon as possible.",
author = "Valeria Brazzelli and Francesca Prestinari and Michela Castello and Eleonora Bellani and Elena Roveda and Tania Barbagallo and Giovanni Borroni",
year = "2005",
month = "5",
doi = "10.1111/j.1525-1470.2005.22319.x",
language = "English",
volume = "22",
pages = "257--261",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm)

AU - Brazzelli, Valeria

AU - Prestinari, Francesca

AU - Castello, Michela

AU - Bellani, Eleonora

AU - Roveda, Elena

AU - Barbagallo, Tania

AU - Borroni, Giovanni

PY - 2005/5

Y1 - 2005/5

N2 - We report our experience with UV-B narrowband (UV-B-NB) therapy in children affected by vitiligo. We studied 10 Caucasian Italian children (six boys, four girls, mean age 9.7 years ± 2.67). Treatment mean term was 5.6 months; frequency was three times a week on nonconsecutive days or only twice a week, because of school or family duties. The percentage of repigmentation was evaluated by comparing photographs taken before, during, and after the treatment, and showed a repigmentation level higher than 75% in five patients (5/10, 50%) and between 26% and 75% in three patients (3/10, 30%). Of our patients, 80% had a satisfactory response to phototherapy. Adverse events were limited and transient. No significant relationships between repigmentation grades and variables such as skin type, positive family history, and disease extension were observed. Some areas responded better than others; the best results were shown on the face and neck. Perhaps we studied too few patients to be conclusive, but the results obtained so far seem to indicate that children affected by recent vitiligo have a better response to the therapy. We feel that UV-B-NB therapy is a valuable and safe option for the treatment of pediatric vitiligo, and should be started as soon as possible.

AB - We report our experience with UV-B narrowband (UV-B-NB) therapy in children affected by vitiligo. We studied 10 Caucasian Italian children (six boys, four girls, mean age 9.7 years ± 2.67). Treatment mean term was 5.6 months; frequency was three times a week on nonconsecutive days or only twice a week, because of school or family duties. The percentage of repigmentation was evaluated by comparing photographs taken before, during, and after the treatment, and showed a repigmentation level higher than 75% in five patients (5/10, 50%) and between 26% and 75% in three patients (3/10, 30%). Of our patients, 80% had a satisfactory response to phototherapy. Adverse events were limited and transient. No significant relationships between repigmentation grades and variables such as skin type, positive family history, and disease extension were observed. Some areas responded better than others; the best results were shown on the face and neck. Perhaps we studied too few patients to be conclusive, but the results obtained so far seem to indicate that children affected by recent vitiligo have a better response to the therapy. We feel that UV-B-NB therapy is a valuable and safe option for the treatment of pediatric vitiligo, and should be started as soon as possible.

UR - http://www.scopus.com/inward/record.url?scp=19644391724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19644391724&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1470.2005.22319.x

DO - 10.1111/j.1525-1470.2005.22319.x

M3 - Article

C2 - 15916579

AN - SCOPUS:19644391724

VL - 22

SP - 257

EP - 261

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

IS - 3

ER -